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A surveillance system to detect West Nile virus (WNV)
was established in Cuba in 2002. WNV infection was con-
firmed by serologic assays in 4 asymptomatic horses and 3
humans with encephalitis in 2003 and 2004. These results
are the first reported evidence of WNV activity in Cuba.
W
est Nile virus was first detected in the Western
Hemisphere during an outbreak of encephalitis in
New York State in 1999 (1). Genetic analyses showed that
the virus responsible for the 1999 outbreak was nearly
identical to a WNV strain circulating in Israel in 1998 (2).
Recent outbreaks of WNV disease in the United States and
Canada have been accompanied by a high proportion of
deaths in birds (3,4), substantial illness in equines (4,5),
and thousands of cases of severe neurologic disease in
humans (6). The range of WNV has rapidly expanded
across the continental United States and Canada (7). WNV
infection in humans, equines, and birds in Mexico (8), the
Caribbean (9), and South and Central America (10,11)
shows southward movement of the virus. Because Cuba is
close to areas of the United States where WNV is endem-
ic and because of recent evidence that suggests spread of
WNV into the Caribbean, surveillance was established to
monitor for WNV in Cuba. Beginning in 2002, the
Medical Services and Ministry of Agriculture and
Veterinarian Services of Cuba established a national sur-
veillance program by using birds, horses, and humans to
detect WNV activity. In this report, we summarize the key
findings of surveillance activities.
The Study
The Ministry of Agriculture and Veterinarian Services
coordinated the collection of dead birds. A total of 1,217
dead birds were shipped at 4°C to the Tropical Medicine
Institute “Pedro Kouri” and identified by ornithology
experts. Brain, heart, and kidneys were removed and test-
ed for WNV by using reverse transcription–polymerase
chain reaction (RT-PCR) (12). Briefly, RNA was extract-
ed by using the QIAmp viral RNA kit (Qiagen, Inc.,
Valencia, CA, USA). Primers WN212 (5′-TTGTGTTG-
GCTCTCTTGGCGTTCTT-3′) and WN619c (5′-CAGC-
CGACAGCACTGGACATTCATA-3′) were used to
detect viral RNA. A second RT-PCR with primers
WN9483 (5′-CACCTACGCCCTAAACACTTTCACC-
3′) and WN9794 (5′-GGAACCTGCTGCCAATCATAC-
CATC-3′) was performed on the same RNA preparation.
Serum specimens from horses in Havana and Havana
Province were tested for antibodies to WNV by using a
competitive enzyme-linked immunosorbent assay
(ELISA) with monoclonal antibodies 3.1112G and 6B6C-
1 as described by Blitvich et al. (13). We tested 210 serum
specimens from horses collected as part of an infectious
anemia study. The immunoglobulin M (IgM) test was not
performed because horses were never suspected of having
WNV and did not have any history of suspected viral
encephalitis or other illness or symptoms. An inhibition
value >30% was used as the diagnostic criterion to identi-
fy flavivirus antibody (Table 1).
The Cuban Health Ministry and Medical Services divi-
sion conducted surveillance for encephalitis of unknown
origin in patients >30 years of age. Serum and cere-
brospinal fluid specimens were shipped at 4°C to the
Tropical Medicine Institute “Pedro Kouri.” Human sera
were screened for WNV IgM and IgG by using commer-
cial IgM and IgG ELISA kits (Focus Technologies,
Cypress, CA, USA) according to manufacturer’s instruc-
tions. Hemagglutination-inhibition (HI) tests were also
undertaken with WNV and Saint Louis encephalitis virus
(SLEV) antigen (14).
Reactive serum samples were further tested by a plaque
reduction neutralization test (PRNT) with WNV (NY99,
Ontario, Canada, 2001 isolate), SLEV (Parton strain,
American Type Culture Collection catalog no. VR-1265),
and dengue virus (dengue 2, NG-C strain). PRNT was per-
formed to confirm WNV-specific antibody and was carried
out as described previously (15) by using a neutral red
double-overlay procedure. Horses or human patients were
considered seropositive for a particular flavivirus if the
90% PRNT titer for that virus was >4-fold greater than the
neutralization titers determined for other viruses used in
the assay. Endpoint titrations were defined as the highest
dilution of serum that reduced plaque formation by >90%.
Most (58%) of the 1,217 birds tested were resident
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malaccas), blue jays (Cyanocitta cristata), herring gulls
(Larus argentatus), yellow-faced grassquits/olive finches
(Tiaris olivacea), and northern parulas (Parula ameri-
cana). None of the birds were positive for WNV RNA by
RT-PCR. We attempted to isolate WNV from most sam-
ples, but virus was not cultured. Most dead birds were
received in good condition for testing.
Nineteen (9.0%) of the 210 horses had serum speci-
mens with antibodies to flaviviruses (Table 1). Four and 8
animals had WNV- and SLEV-specific antibodies, respec-
tively, in the PRNT. Two horses seropositive for WNV
came from Havana City, and 2 others came from Havana
Province. Seven serum samples had antibodies to undeter-
mined flaviviruses on the basis of results of neutralization
assays, and further virus characterization was not per-
formed. None of the horses, including those that were pos-
itive for flavivirus antibodies, showed any signs of illness
at the time of serum collection.
Serum specimens from 13 patients with encephalitis
were tested for possible WNV infection. Two of these
patients (M.M. and K.R.) were identified as part of WNV
surveillance in 2003. Both acute-phase and convalescent-
phase serum specimens from these patients were positive
for flavivirus antibody by IgM and IgG ELISAs (Table 2).
Cerebrospinal fluid from patient K.R. was also positive for
IgM by WNV ELISA. Acute-phase and convalescent-
phase serum samples from M.M. and K.R. were also posi-
tive by HI assay and showed seroconversion to WNV.
Convalescent-phase serum samples were tested for WNV-
specific antibody by PRNT, and the neutralization titers
were 320 and 160, respectively. Neutralizing antibodies
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serum specimens of either patient. These persons are the
first to have confirmed cases of WNV-associated illness in
Cuba. Both patients had histories of febrile illness, muscle
weakness, and encephalitis, and both were hospitalized.
These persons had jobs that required them to spend large
amounts of time outdoors, and they lived in communities
in Santi Spiritus and Villa Clara in central Cuba. Another
person (O.G., Table 2), who also resided in Santi Spiritus,
had a low WNV titer by HI assay but had neutralizing anti-
bodies to WNV, which suggests a past WNV infection.
This patient was identified during surveillance in 2004 but
may have been exposed to WNV in 2003.
Serum specimens from the 10 remaining patients were
negative for WNV IgM but were positive for flavivirus IgG
by ELISA; most of these were also positive by HI assay
(Table 2). One person appeared to have been exposed to
dengue virus, and 4 had antibodies to unidentified fla-
viviruses. Five patients had serum with SLEV-specific anti-
bodies. Seroconversions were not demonstrated in any of
these persons, so we cannot say whether their illnesses were
associated with SLEV or dengue virus infections.
Conclusions
We report the first evidence of antibodies to WNV in
horses and humans in Cuba. The fact that human and horse
infections have been detected strongly suggests that a local
amplification cycle has been established in Cuba. The
mode of entry of the virus into Cuba is unknown.
In North America, avian death from WNV infection has
been well documented (3–5). However, none of the dead
birds collected during this study showed evidence of viral
infection. Although 1,217 animals were tested, a more
intensive dead bird surveillance program may be needed to
identify animals that die from WNV infection. Resident
bird species in Cuba may be less susceptible to WNV
infection, and death rates among birds in the Caribbean
may be lower than those observed in Canada and the
United States.
This study also provides evidence that suggests WNV
and SLEV may co-circulate in Cuba. Further studies are
required to confirm these observations and to characterize
the transmission cycles involved. Finally, expansion of
existing mosquito control programs in Cuba, which cur-
rently focus on Aedes aegypti and dengue prevention, may
be required to respond to this new public health threat.
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